English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1720]
News [2696]
Articles [104]
Editorials [3]
Conferences [89]
elearning [4]
Third dose of COVID-19 vaccine increases immune responses most blood cancer patients, though some deficits remain
Third dose of COVID-19 vaccine increases immune responses most blood cancer patients, though some de...
Vaccine protects most cancer patients from COVID, but risk remains higher for patients with blood cancers
Vaccine protects most cancer patients from COVID, but risk remains higher for patients with blood ca...
Gene deletion behind anomaly in blood cancer cells
Gene deletion behind anomaly in blood cancer cells
FDA approves axicabtagene ciloleucel for second-line treatment of large B-cell lymphoma
FDA approves axicabtagene ciloleucel for second-line treatment of large B-cell lymphoma
New gene targets for treating adult blood cancer
New gene targets for treating adult blood cancer
The tumour cells of a type of childhood leukaemia block the formation of new neurones
The tumour cells of a type of childhood leukaemia block the formation of new neurones
Genetic ancestry matters in childhood leukaemia treatment success
Genetic ancestry matters in childhood leukaemia treatment success
Axi-cel proves effective as first-line treatment for high-risk lymphoma
Axi-cel proves effective as first-line treatment for high-risk lymphoma
Scientists discover a new pathogenic mechanism in haematological malignancies
Scientists discover a new pathogenic mechanism in haematological malignancies
How do gut microbes affect the success of CAR T immunotherapy?
How do gut microbes affect the success of CAR T immunotherapy?
<123456...270>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307